NAT2 and choroidal neovascularization: The data of NAT2 showed that the incidence of choroidal neovascularization (CNV) in patients with unilateral exudative AMD (unilateral exudative AMD) with high plasma concentrations of DHA and EPA decreased significantly for three consecutive years.